Schultz M J, Millo J, Levi M, Hack C E, Weverling G J, Garrard C S, van der Poll T
Department of Intensive Care Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Thorax. 2004 Feb;59(2):130-5. doi: 10.1136/thorax.2003.013888.
Fibrin deposition is a hallmark of pneumonia. To determine the kinetics of alterations in local coagulation and fibrinolysis in relation to ventilator associated pneumonia (VAP), a single centre prospective study of serial changes in pulmonary and systemic thrombin generation and fibrinolytic activity was conducted in patients at risk for VAP.
Non-directed bronchial lavage (NBL) was performed on alternate days in patients expected to require mechanical ventilation for more than 5 days. A total of 28 patients were studied, nine of whom developed VAP.
In patients who developed VAP a significant increase in thrombin generation was observed in the airways, as reflected by a rise in the levels of thrombin-antithrombin complexes in NBL fluid accompanied by increases in soluble tissue factor and factor VIIa concentrations. The diagnosis of VAP was preceded by a decrease in fibrinolytic activity in NBL fluid. Indeed, before VAP was diagnosed clinically, plasminogen activator activity levels in NBL fluid gradually declined, which appeared to be caused by a sharp increase in NBL fluid levels of plasminogen activator inhibitor 1.
VAP is characterised by a shift in the local haemostatic balance to the procoagulant side, which precedes the clinical diagnosis of VAP.
纤维蛋白沉积是肺炎的一个标志。为了确定与呼吸机相关性肺炎(VAP)相关的局部凝血和纤维蛋白溶解改变的动力学,对有VAP风险的患者进行了一项关于肺和全身凝血酶生成及纤维蛋白溶解活性系列变化的单中心前瞻性研究。
预计需要机械通气超过5天的患者每隔一天进行一次非定向支气管灌洗(NBL)。共研究了28例患者,其中9例发生了VAP。
在发生VAP的患者中,气道内凝血酶生成显著增加,这表现为NBL液中凝血酶 - 抗凝血酶复合物水平升高,同时可溶性组织因子和因子VIIa浓度增加。VAP诊断之前,NBL液中的纤维蛋白溶解活性降低。事实上,在临床诊断VAP之前,NBL液中纤溶酶原激活物活性水平逐渐下降,这似乎是由NBL液中纤溶酶原激活物抑制剂1水平急剧增加所致。
VAP的特征是局部止血平衡向促凝侧转变,这发生在VAP临床诊断之前。